- Pharmaceutical Executive-10-01-2021
- Volume 41
- Issue 10
Talent & Careers 2022
Examining the incumbent and imminent workforce.
First, it was talking through with my son what degree he should add to his biochemistry major, now that he is in his sophomore year of college. Second, it was Elaine Quilici’s column last month on the upheaval in human resources throughout the biopharma industry. And third, a LinkedIn article on the fastest growing C-suite roles across all industries. Wherever we look as an industry, there remains an insistent need to find, nurture, and grow talent.
his becomes very evident from a recent
Incumbent workforce
The MassBioEd report noted that the most challenging positions to fill in the state this year are regulatory affairs, research scientists, data sciences (computational biology/statistics), and engineering and product and/or process development. The areas that will be in high-demand in 2022 include manufacturing and production, quality control/assurance, and research scientists.
The incumbent workforce is in flux, as noted in the above
MassBioEd roundtable discussions noted following potential solutions to these pain points: openness to hiring candidates from non-traditional backgrounds; transparency in career ladders within companies to outline scientific tracks vs. tracks that lead to management; and a continued focus on inclusion and belonging to ensure employees once hired, feel secure and valued.
Internal server error